Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
3.650
-0.040 (-1.08%)
At close: Jul 15, 2026, 4:00 PM EDT
3.660
+0.010 (0.27%)
After-hours: Jul 15, 2026, 4:10 PM EDT
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $218.56 million as of July 15, 2026. Its market cap has increased by 112.87% in one year.
Market Cap
218.56M
Enterprise Value
140.01M
1-Year Change
112.87%
Ranking
Category
Stock Price
$3.65
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $218.56M, an increase of 10.70%. That is a compound annual growth rate of 1.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 218.56M | -6.73% |
| Dec 31, 2025 | 234.33M | 54.11% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protara Therapeutics | 233.53M |
| Camp4 Therapeutics | 232.63M |
| Agenus | 231.53M |
| Nautilus Biotechnology | 228.74M |
| Karyopharm Therapeutics | 227.31M |
| Precision BioSciences | 225.51M |
| Coherus Oncology | 224.43M |
| Anavex Life Sciences | 223.80M |